What patent owners need to know about financing life sciences disputes

The Long Read: Companies in the life sciences sector have increasing options when seeking outside investment in IP enforcement campaigns, writes Michael Gulliford. But unique legal considerations and risk factors call for careful structuring of deals

Get unlimited access to all IAM content